Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years-Reference-Cited by-同舟云学术

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years

Published:2022-08-19 Issue:S3 Volume:130 Page:40-45
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Yaxley William John¹²^ORCID,Mackean James³⁴,Desai Devang J.⁵,Tsang Gail³⁴,Dixon Judi⁶,Samaratunga Hemamali⁷,Delahunt Brett⁸,Egevad Lars⁹^ORCID,Gardiner Robert A.²,Yaxley John William²⁴⁶¹⁰^ORCID

Affiliation:

1. Queen Elizabeth II Jubilee Hospital Brisbane QLD Australia

2. School of Medicine The University of Queensland Brisbane QLD Australia

3. Genesis Cancer Care Brisbane QLD Australia

4. Wesley Hospital Brisbane QLD Australia

5. Toowoomba Hospital Toowoomba QLD Australia

6. Wesley Urology Clinic Wesley Hospital Brisbane QLD Australia

7. Aquesta Uropathology Brisbane QLD Australia

8. Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences University of Otago Wellington New Zealand

9. Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

10. Royal Brisbane and Women's Hospital Brisbane QLD Australia

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15845

Reference30 articles.

1. Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer

2. Patterns of Recurrence After Low-Dose-Rate Prostate Brachytherapy: A Population-Based Study of 2223 Consecutive Low- and Intermediate-Risk Patients

3. Radical prostatectomy versus brachytherapy for clinically localized prostate cancer on oncological and functional outcomes: a meta-analysis

4. Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis

5. Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study